Skip to content
Our Company
Pipeline
Science
Investors
Careers
Contact
1st March 2025
Dual Targeting of Mast Cells and TSLP with the Bispecific Antibody CDX-622
1st February 2025
Dual Inhibition of Mast Cells and Thymic Stromal Lymphopoietin Using a Novel Bispecific Antibody, CDX-622
1st May 2023
Dual Targeting of Mast Cells and TSLP with a Bispecific Antibody
Top